Johnson & Johnson Q1 FY26: where the revenue came from and where it went
The whole income statement of Johnson & Johnson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Dec 29, 2025 – Mar 29, 2026
- Reported
- Apr 22, 2026
Revenue$24.1B
+10% year over year
Gross profit$16.0B
66% margin
Operating profit$6.4B
27% margin
Net profit$5.2B
22% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 24.1 | 100% | +10% |
| Innovative medicine | 15.4 | 64% | +11% |
| Med tech | 8.6 | 36% | +8% |
| Cost of revenue | −8.1 | 34% | |
| Gross profit | 16.0 | 66% margin | +0pp |
| SG&A | −6.0 | 25% | +2pp |
| Other | −3.5 | 15% | +0pp |
| Operating profit | 6.4 | 27% margin | +0pp |
| Interest & other costs | −0.4 | ||
| Tax | −0.8 | ||
| Net profit | 5.2 | 22% margin | −28pp |
304 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest